Menu
Back to Journals » OncoTargets and Therapy » Volume 8
Original Research
Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,923 | Dovepress* | 11,120+ | 1,874 | 12,994 | |
| PubMed Central* | 803 | 392 | 1,195 | ||
| Totals | 11,923 | 2,266 | 14,189 | ||
|
*Since 25 February 2015 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar